Condensed Balance Sheets (unaudited) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 27,716	$ 66,346
Short-Term Investments	59,702	40,379
Prepaid expenses and other current assets	2,728	1,659
Total current assets	90,146	108,384
Right-of-use assets	355	521
Property and equipment	12	14
Other long-term assets	0	33
Total assets	90,513	108,952
Current liabilities:
Accounts payable	602	1,028
Accrued research and development expenses	4,215	2,245
Accrued compensation and related expenses	1,019	1,480
Accrued other expenses	1,345	352
Right-of-use liabilities, current portion	363	339
Total current liabilities	7,544	5,444
Right-of-use liabilities, net of current portion	0	185
Commitments and contingencies (see Note 9)
Stockholders’ equity (deficit):
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1	1
Additional paid-in-capital	146,953	145,683
Accumulated other comprehensive loss	(784)	(164)
Accumulated deficit	(63,201)	(42,197)
Total stockholder’s equity (deficit)	82,969	103,323
Total liabilities, convertible preferred stock and shareholders’ equity (deficit)	90,513	108,952
Non-Voting Common Stock [Member]
Stockholders’ equity (deficit):
Common Stock, Value, Issued	$ 0	$ 0